Dr. Stephen Parker
Stephen has over twenty years of working with and within the biotechnology and pharmaceutical industries. He has experience within the biotechnology sector as Chief Financial Officer of Oxford GlycoSciences (“OGS”) (2000-2002) and through several interim CEO projects. At OGS he played a leading role in raising £170m in the largest UK follow-on equity fund raising for a biotechnology company and led the creation of a joint-venture, Confirmant Limited, with Marconi PLC to exploit database applications of the proteomics platform. He is co-Founder of the UK Stem Cell Foundation with Sir Christopher Evans, which has been created to provide funding to bring stem cell-based therapies against some of the major diseases in the western world to patients in clinical trials in the UK.
Prior to entering the sector, he was a healthcare sector investment banker with experience in both big Pharma (clients included Roussel Uclaf, Wellcome and Zeneca) and biotechnology (Celltech, Chiroscience, Corixa, Serono and Triangle Pharmaceuticals). He was a senior banker with Baring’s, Warburg’s and Apax Partners. Stephen also has experience as a strategic consultant with PA Consulting Group. His consulting clients included Boehringer Mannheim, Ciba-Geigy, Gist-brocades, Rhône-Poulenc Rorer, SmithKline Beecham and Warner-Lambert.
Stephen holds a DPhil. in biochemistry from Oxford University and an MBA from City University, London and served on the Finance Committee of the UK BioIndustry Association from 2001 to 2009.
